Bipolar Research - Bipolar Disorder, Symptoms, Treatment, Depression, Medication

Bipolar Research Today is a free monthly online journal that collates and summarizes the latest research about Bipolar, including details on bipolar disorder, symptoms, treatment, depression, medication.


Bipolar Research Today

Home

View Latest Issue

Information About Bipolar

Books on Bipolar

Advertising in Research Today

View Other Research Today Publications



Volume 3 (2006), Issue 4 (April)

  1. Reduced Glucocorticoid Receptor alpha Expression in Mood Disorder Patients and First-Degree Relatives.
    Biol Psychiatry, 59(8): 689-95. [Abstract] [Full-text]
  2. A point mutation at the calreticulin gene core promoter conserved sequence in a case of schizophrenia.
    Am J Med Genet B Neuropsychiatr Genet, 141(3): 294-5. [Abstract] [Full-text]
  3. Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with schizophrenia in the Japanese population.
    Am J Med Genet B Neuropsychiatr Genet, 141(3): 301-4. [Abstract] [Full-text]
  4. Suggestive evidence for association of the circadian genes PERIOD3 and ARNTL with bipolar disorder.
    Am J Med Genet B Neuropsychiatr Genet, 141(3): 234-41. [Abstract] [Full-text]
  5. Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder.
    Br J Psychiatry, 188: 366-73. [Abstract] [Full-text]
  6. What can we conclude from studies on psychotherapy in bipolar disorder? Invited commentary on...Cognitive-behavioural therapy for severe and recurrent bipolar disorders.
    Br J Psychiatry, 188: 321-2. [Abstract] [Full-text]
  7. Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial.
    Br J Psychiatry, 188: 313-20. [Abstract] [Full-text]
  8. Variation at the DAOA/G30 locus influences susceptibility to major mood episodes but not psychosis in schizophrenia and bipolar disorder.
    Arch Gen Psychiatry, 63(4): 366-73. [Abstract] [Full-text]
  9. Validity of the Distinction Between Primary and Secondary Substance Use Disorder in Patients with Bipolar Disorder: Data from the First 1000 STEP-BD Participants.
    Am J Addict, 15(2): 138-43. [Abstract] [Full-text]
  10. Atypical antipsychotic-induced akathisia with depression: therapeutic role of mirtazapine.
    Ann Pharmacother, 40(4): 771-4. [Abstract] [Full-text]
  11. Translating research into clinical practice: critical interpretation of clinical trials in schizophrenia.
    Int Clin Psychopharmacol, 21: S1-S10. [Abstract] [Full-text]
  12. A prospective high-risk study of the association among maternal negativity, apparent frontal lobe dysfunction, and the development of bipolar disorder.
    Dev Psychopathol, 18(2): 573-89. [Abstract] [Full-text]
  13. Impaired cognition and decision-making in bipolar depression but no 'affective bias' evident.
    Psychol Med, 36(5): 629-39. [Abstract] [Full-text]
  14. A prospective study of the transition rates of subthreshold (hypo)mania and depression in the general population.
    Psychol Med, 36(5): 619-27. [Abstract] [Full-text]
  15. Structural brain correlates of IQ changes in bipolar disorder.
    Psychol Med, 36(5): 609-18. [Abstract] [Full-text]
  16. In this issue.
    Psychol Med, 36(5): 573-4. [Abstract] [Full-text]
  17. The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers.
    Curr Opin Psychiatry, 19(3): 313-23. [Abstract] [Full-text]
  18. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug.
    Braz J Med Biol Res, 39(4): 421-9. [Abstract] [Full-text]
  19. Safety and tolerability of mood-stabilising anticonvulsants in the elderly.
    Expert Opin Drug Saf, 5(3): 401-16. [Abstract] [Full-text]
  20. Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia.
    J Nerv Ment Dis, 194(4): 255-60. [Abstract] [Full-text]
  21. Comorbid medical and psychiatric conditions and substance abuse in HCV infected persons on dialysis.
    J Hepatol, 44(5): 864-8. [Abstract] [Full-text]
  22. Is Competition between Li(+) and Mg(2+) the Underlying Theme in the Proposed Mechanisms for the Pharmacological Action of Lithium Salts in Bipolar Disorder?
    Acc Chem Res, 39(4): 283-91. [Abstract] [Full-text]
  23. Cognitive compromise in bipolar disorder with chronic cannabis use: cause or consequence?
    Expert Rev Neurother, 6(4): 591-8. [Abstract] [Full-text]
  24. Biosynthesis of dermatan sulfate: chondroitin-glucuronate C5-epimerase is identical to SART2.
    J Biol Chem, 281(17): 11560-8. [Abstract] [Full-text]
  25. Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results.
    J Clin Psychopharmacol, 26(2): 178-81. [Abstract] [Full-text]
  26. Social anxiety disorder comorbidity in patients with bipolar disorder: A clinical replication.
    J Anxiety Disord. [Abstract] [Full-text]
  27. Neural stem cell proliferation is decreased in schizophrenia, but not in depression.
    Mol Psychiatry, 11(5): 514-22. [Abstract] [Full-text]
  28. Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes.
    Neurosci Lett, 398(3): 215-9. [Abstract] [Full-text]
  29. XBP1 induces WFS1 through an endoplasmic reticulum stress response element-like motif in SH-SY5Y cells.
    J Neurochem, 97(2): 545-55. [Abstract] [Full-text]
  30. Use of phenotypic covariates in association analysis by sequential addition of cases.
    Eur J Hum Genet, 14(5): 529-34. [Abstract] [Full-text]
  31. Clinical outcome in patients with bipolar I disorder, obsessive compulsive disorder or both.
    Hum Psychopharmacol, 21(3): 189-93. [Abstract] [Full-text]
  32. Comparisons of perceived quality of life across clinical states in bipolar disorder: data from the first 2000 Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) participants.
    Compr Psychiatry, 47(3): 161-8. [Abstract] [Full-text]
  33. The role of quetiapine in the treatment of bipolar disorder.
    Expert Opin Pharmacother, 7(7): 929-40. [Abstract] [Full-text]
  34. Lack of pharmacokinetic interaction between lamotrigine and olanzapine in healthy volunteers.
    Pharmacotherapy, 26(5): 627-33. [Abstract] [Full-text]
  35. Lamotrigine-associated anticonvulsant hypersensitivity syndrome in bipolar disorder.
    Prog Neuropsychopharmacol Biol Psychiatry, 30(4): 741-4. [Abstract] [Full-text]
Place a permanent text-link or advertisement here for just US$15.

© 2004-2008 Bipolar Research Today. All Rights Reserved.



Bipolar Research Today Archive:

Volume 1 (2004)
  Issue 1 (September)
  Issue 2 (October)
  Issue 3 (November)
  Issue 4 (December)

Volume 2 (2005)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 3 (2006)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 4 (2007)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)
  Issue 8 (August)
  Issue 9 (September)
  Issue 10 (October)
  Issue 11 (November)
  Issue 12 (December)

Volume 5 (2008)
  Issue 1 (January)
  Issue 2 (February)
  Issue 3 (March)
  Issue 4 (April)
  Issue 5 (May)
  Issue 6 (June)
  Issue 7 (July)



Bipolar Books

Exuberance: The Passion for Life

Exuberance: The Passion for Life